Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
VTGN similar filings
- 18 Sep 20 2020 Virtual Annual Meeting of Stockholders
- 14 Aug 20 VistaGen Therapeutics Reports Fiscal 2021 First Quarter Financial Results and Highlights CNS Pipeline and Business Progress
- 5 Aug 20 VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock
- 24 Jul 20 Regulation FD Disclosure
- 30 Jun 20 VistaGen Therapeutics Reports Fiscal Year 2020 Results and Provides CNS Pipeline Update
- 26 Jun 20 Collaboration intended to support Phase 3 development and commercialization of PH94B in key Asian markets
- 1 Jun 20 VistaGen and Nuformix Announce Agreement to Develop Novel Patentable Cocrystalline Forms of AV-101 for Treatment of Multiple CNS Conditions
Filing view
External links